Last week was an incredible week for many reasons as discussed the Weekly Market Update.
From the post;
Biotechnology stocks have been under the microscope (yes, that was a pun) first for years of outperformance and lately weeks of under performance. The latest attention came from Candidate Clinton who Tweeted of price gouging after the Daraprim story broke (the $7.50 pill whose price was temporarily jacked up 5000%) and then offered a plan to cap the costs of prescription drugs. If this was not good for the drug companies broadly, the sector down by 5% on the week, then it was very bad for biotech with the larger biotech ETFs dropping close to 15% on the week.
Please click through to read the entire post.
There was a Corvette show in downtown Prescott this weekend.